Tag: IVD
LordsMed expands global footprint with launch of export division for diagnostic...
The manufacturing facilities located in the outskirts of Mumbai, currently has the capacity to facilitate an impressive 1.7 crore diagnostic tests per month
TechInvention Lifecare & Reagent IVD Resources collaborate on development & manufacturing...
The portfolio would encompass human as well as veterinary segments for global supplies
Cipla launches Cippoint – a point-of-care device for non-communicable, infectious diseases
Point-of-Care solution to facilitate clinicians in quick and effective decision making
LordsMed launches advanced multidisciplinary 20,000 sq. ft. IVD manufacturing facility in...
The company plans to invest Rs. 33 crores to scale the IVD facility; the plant has the capacity to facilitate 1.7 crore tests per month
Genes2Me launches CoviEasy, a self-test kit for Covid-19
CoviEasy has undergone stringent quality checks at ICMR approved Validation center and further received approval from CDSCO India
ADMI announces new leadership team
The new leadership was formally handed charge by Veena Kohli, the outgoing President, at the AGM in Mumbai
BD launches high-throughput molecular combination test for COVID-19 & Influenza A/B
Second Test for the BD COR™ MX to be CE Marked to IVD Directive
Fujifilm showcases new range of CT, MRI & ultrasound machines at...
Offering a diverse portfolio, the new range will include solutions pertaining to CT, MRI, Digital Radiography, AI, PACS, endoscopy, IVD and ultrasound systems
Roche Diagnostics earns Frost & Sullivan 2021-India Competitive Strategy Leadership Award
Each year, Frost & Sullivan presents this award to the company that leverages competitive intelligence to successfully execute a strategy that results in stronger market share, competitive brand positioning, and customer satisfaction
“Pandemic has led to renewed focus on preventive healthcare”
In an exclusive interview with BioVoice, Managing Director of J Mitra & Company, Jatin Mahajan shared his views on various aspects related to COVID-19 besides the details of his company’s latest activities, and much more.......................